Stingeni, L., Ravasio, R., Palladino, C., Di Fino, S., Levi, A., Ronci, G. and Gisondi, P. 2025. Cost per responder of upadacitinib 30 mg and dupilumab 300 mg in patients with moderate-to-severe atopic dermatitis in italy. Global and Regional Health Technology Assessment. 12, 1 (Mar. 2025), 70–79. DOI:https://doi.org/10.33393/grhta.2025.3458.